1
|
Aitken SJ, Allard B, Altaf N, Atkinson N, Aziz O, Battersby R, Benson R, Chambers JL, Charlton G, Coleman C, Dawson JA, Dean A, Dhal BS, Fitridge R, Gan J, Hanna J, Hattam AT, Hein M, Hon K, Khoo S, Kilby J, Kuang B, Leong KW, Lim E, Liu JWN, McClure DN, Mehta S, Moss JL, Muller J, Musicki K, Nandhra S, Papanikolas MJ, Pineda FP, Pond F, Ravintharan N, Richards T, Saeed H, Selvaraj CN, Singh G, Sivakumaran Y, Stavert BM, Suthers E, Tang R, Varley VC, Vasudevan TM, Vo UG, Wagner T, Wang J, Wong J. Frail patients having vascular surgery during the early COVID-19 pandemic experienced high rates of adverse perioperative events and amputation. ANZ J Surg 2022; 92:2305-2311. [PMID: 35674397 PMCID: PMC9347445 DOI: 10.1111/ans.17810] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2022] [Revised: 04/26/2022] [Accepted: 05/04/2022] [Indexed: 01/20/2023]
Abstract
BACKGROUND Frailty predicts adverse perioperative outcomes and increased mortality in patients having vascular surgery. Frailty assessment is a potential tool to inform resource allocation, and shared decision-making about vascular surgery in the resource constrained COVID-19 pandemic environment. This cohort study describes the prevalence of frailty in patients having vascular surgery and the association between frailty, mortality and perioperative outcomes. METHODS The COVID-19 Vascular Service in Australia (COVER-AU) prospective cohort study evaluates 30-day and six-month outcomes for consecutive patients having vascular surgery in 11 Australian vascular units, March-July 2020. The primary outcome was mortality, with secondary outcomes procedure-related outcomes and hospital utilization. Frailty was assessed using the nine-point visual Clinical Frailty Score, scores of 5 or more considered frail. RESULTS Of the 917 patients enrolled, 203 were frail (22.1%). The 30 day and 6 month mortality was 2.0% (n = 20) and 5.9% (n = 35) respectively with no significant difference between frail and non-frail patients (OR 1.68, 95%CI 0.79-3.54). However, frail patients stayed longer in hospital, had more perioperative complications, and were more likely to be readmitted or have a reoperation when compared to non-frail patients. At 6 months, frail patients had twice the odds of major amputation compared to non-frail patients, after adjustment (OR 2.01; 95% CI 1.17-3.78), driven by a high rate of amputation during the period of reduced surgical activity. CONCLUSION Our findings highlight that older, frail patients, experience potentially preventable adverse outcomes and there is a need for targeted interventions to optimize care, especially in times of healthcare stress.
Collapse
Affiliation(s)
| | - Sarah J Aitken
- Concord Repatriation General Hospital, Sydney, NSW, Australia
| | | | | | | | - Omar Aziz
- Nepean Hospital, Sydney, NSW, Australia
| | | | - Ruth Benson
- Vascular and Endovascular Research Network, Birmingham, UK
| | | | | | | | | | | | | | | | - John Gan
- Port Macquarie Base Hospital, Port Macquarie, NSW, Australia
| | | | | | | | - Kay Hon
- Royal Adelaide Hospital, Adelaide, SA, Australia
| | - Samantha Khoo
- Concord Repatriation General Hospital, Sydney, NSW, Australia
| | - Joseph Kilby
- University Hospital Geelong, Geelong, VIC, Australia
| | | | | | - Eunice Lim
- Concord Repatriation General Hospital, Sydney, NSW, Australia
| | - Ju-Wei N Liu
- Concord Repatriation General Hospital, Sydney, NSW, Australia
| | | | - Shreya Mehta
- Concord Repatriation General Hospital, Sydney, NSW, Australia
| | | | | | | | - Sandip Nandhra
- Vascular and Endovascular Research Network, Birmingham, UK
| | | | | | | | | | | | - Hani Saeed
- Western Health, Melbourne, VIC, Australia
| | | | | | | | | | | | | | | | | | - Uyen G Vo
- Fiona Stanley Hospital, Perth, WA, Australia
| | | | - Judy Wang
- University Hospital Geelong, Geelong, VIC, Australia
| | | |
Collapse
|
2
|
Buchanan DAS, Owen D, Angliss R, McClure DN. Acute subclavian artery occlusion with associated clavicle fracture managed with bypass graft alone. BMJ Case Rep 2018; 2018:bcr-2018-224719. [PMID: 29954765 DOI: 10.1136/bcr-2018-224719] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
Subclavian artery injury is a rare consequence of clavicle fracture. It most often results from penetrating trauma but can result from blunt trauma with adjacent bone fragments causing rupture, pseudoaneurysm, dissection or thrombosis of the artery. If flow through the subclavian artery is compromised there is a risk of ipsilateral upper limb ischaemia. Life-threatening haemorrhage may result in cases of laceration, and cerebral infarction may result from dissection. Vascular injury in association with clavicle fracture is typically regarded as an indication for internal fixation of the fracture. We present a case of subclavian artery thrombosis in association with a comminuted midshaft clavicle fracture causing limb ischaemia managed by carotid to brachial artery bypass without internal fracture fixation. The fracture united at 4 weeks and there was no sustained vascular or neurological impairment at follow-up. We advocate urgent vascular intervention in subclavian artery injury. There is little discussion in the literature regarding non-operative management of clavicle fractures with subclavian artery injury. We suggest that select clavicle fractures with subclavian artery injury can be safely managed non-operatively.
Collapse
Affiliation(s)
- Dougal A S Buchanan
- Department of Vascular and Endovascular Surgery, Barwon Health, Geelong, Victoria, Australia
| | - David Owen
- Department of Orthopaedic Surgery, Barwon Health, Geelong, Victoria, Australia
| | - Richard Angliss
- Department of Orthopaedic Surgery, Barwon Health, Geelong, Victoria, Australia
| | - David N McClure
- Department of Vascular and Endovascular Surgery, Barwon Health, Geelong, Victoria, Australia
| |
Collapse
|
3
|
Abstract
INTRODUCTION The post-Carotid Revascularization Endarterectomy versus Stenting Trial era has seen a dramatic decline in the practice of carotid artery stenting (CAS). A retrospective review of prospectively collected CAS outcomes over a 10-year period by a single operator was undertaken to determine if this change in practice is justified and to identify the place of carotid stenting in current practice. METHODS One hundred fifty-nine carotid stent procedures were undertaken on 137 patients from 2002 to 2012. Cases were selected for CAS only if they fulfilled the inclusion criteria for the SAPPHIRE trial. Post-procedural outcomes were compared against those of a contemporaneous cohort of patients undergoing carotid endarterectomy (CEA) by the same operator and against published meta-analyses. The measure of CAS durability was need for re-intervention, based on the presence of ultrasound-detected re-stenosis >70%. RESULTS No significant difference was identified in 30-days' complication rates between patients undergoing CAS and those having CEA. Compared to published meta-analyses of CAS, our practice was accompanied by a significantly lower rate of peri-procedural stroke (1.26% versus 6%, P = 0.014) while carrying equivalent 30-days' death and myocardial infarction. Four stented arteries had re-intervention, due to asymptomatic in-stent stenosis of >70%. Further intervention was declined in a fifth case. This represents a re-stenosis rate of 3.1% over a mean follow-up of 40.2 ± 27.6 months. DISCUSSION CAS can provide a safe and durable treatment option for selected patients with carotid artery disease, in the hands of appropriately trained proceduralists who meet accepted standards of practice.
Collapse
Affiliation(s)
- Nathan G Biggs
- School of Medicine, Deakin University, Geelong, Victoria, Australia.,Department of Vascular and Endovascular Surgery, The Geelong Hospital, Geelong, Victoria, Australia
| | - Shrikkanth Rangarajan
- Department of Vascular and Endovascular Surgery, The Geelong Hospital, Geelong, Victoria, Australia
| | - David N McClure
- School of Medicine, Deakin University, Geelong, Victoria, Australia.,Department of Vascular and Endovascular Surgery, The Geelong Hospital, Geelong, Victoria, Australia.,Geelong Vascular Service, Deakin University, Geelong, Victoria, Australia
| |
Collapse
|